drugset
drugset / Trial / NCT02120287

Border Zone Stereotactic Radiosurgery With Bevacizumab in Patients With Glioblastoma Multiforme

NCT02120287 ↗

Phase 2 Completed 16 enrolled Ajay Niranjan Genentech, Inc. · collab
NaSingle-groupOpen-labelTreatment

Summary

This is a phase II study on the usage of stereotactic Gamma Knife radiosurgery as a boost to the tumor bed border zone in conjunction with the usage of bevacizumab.

Timeline

Start
2014-05
Primary completion
2018-03-31
Completion
2018-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Bevacizumab Monoclonal antibody 10 mg/kg —

Indications

glioblastoma